Dr. Vijayalakshmi Kancharla is a Research Associate at the Texas Health Center, Houston, specializing in molecular biology, neurodegenerative diseases, and analytical chemistry. She holds a Ph.D. in Analytical Chemistry from GITAM University, India, with research focused on advanced chromatographic methods for drug analysis and validation. Her current work investigates the role of long non-coding RNAs (lncRNAs) in neurodegenerative and neurotraumatic disorders, integrating molecular, cellular, and behavioral approaches.

Dr. Kancharla has extensive experience in antibody discovery, exosome characterization, and translational biomedical research, with prior training at the Mayo Clinic, USA. She has contributed to the development of single-chain variable fragment (scFv) antibodies targeting various disease markers, with potential diagnostic and therapeutic applications. Her industry experience includes several years at Divi’s Laboratories, where she worked on pharmaceutical quality control, analytical method development, and drug validation.

An active contributor to the scientific community, Dr. Kancharla has authored multiple peer-reviewed publications and serves as a technical reviewer for scientific journals. Her research interests span neurobiology, molecular therapeutics, and analytical method development, reflecting a strong commitment to advancing interdisciplinary biomedical research.